In Brief PAR polarity pathway-mediated cell polarization relies on a conserved network of proteins including PAR-3, CDC-42, PAR-6, and aPKC. Rodriguez, Peglion et al. uncover a division of labor whereby PAR-6 and aPKC cycle between distinct cue-sensing and effector assemblies that act cooperatively to polarize the one-cell C. elegans zygote.
INTRODUCTION
A crucial step in the polarization of metazoan cells is the localization of conserved sets of polarity effectors, known as the partitioning-defective or PAR proteins, to discrete membrane-associated cortical domains. Regulation of PAR protein distribution is essential for the localized activation of signaling pathways that coordinate many aspects of embryonic development, including asymmetric cell division, epithelial organization, and embryo axis establishment (Goldstein and Macara, 2007; St Johnston and Ahringer, 2010) . Although the precise details vary between systems, in most cases the conserved PDZ domain proteins PAR-3 and PAR-6, the small guanosine triphosphatase (GTPase) CDC-42 and atypical protein kinase C (aPKC) act together to establish polarity on one side of the cell and drive asymmetry of a range of downstream pathways (reviewed in Goehring, 2014; Suzuki et al., 2004; Ziomek et al., 1982) .
In Caenorhabditis elegans, PAR-3, PAR-6, CDC-42, and the aPKC ortholog, PKC-3, play an essential role in polarizing the one-cell embryo or zygote by defining an anterior domain and hence are referred to as anterior PARs or aPARs . An opposing set of posterior PARs or pPARs, consisting of PAR-1, PAR-2, LGL-1, and the CDC-42 GAP, CHIN-1, form a complementary domain at the posterior. Together, aPARs and pPARs define the anterior-posterior axis of the zygote and orchestrate an asymmetric division that restricts germline determinants to the posterior daughter cell (Beatty et al., 2010; Boyd et al., 1996; Etemad-Moghadam et al., 1995; Gotta et al., 2001; Guo and Kemphues, 1995; Hoege et al., 2010; Kay and Hunter, 2001; Kumfer et al., 2010; Tabuse et al., 1998; Watts et al., 1996) .
Polarization is triggered by the sperm-donated centrosome via two semi-redundant pathways (Figures 1A and 1B) . First, the centrosome induces actomyosin cortical flow away from the newly defined posterior pole, which transports membrane-associated aPAR proteins into the anterior (Cheeks et al., 2004; Goehring et al., 2011b; Mayer et al., 2010; Munro et al., 2004) . Second, centrosomal microtubules promote local loading of PAR-2 in the posterior. PAR-2 then recruits PAR-1, which drives posterior exclusion of aPARs through phosphorylation of PAR-3 Hao et al., 2006; Motegi et al., 2011) . Following this ''establishment phase,'' the zygote enters a ''maintenance phase'' during which mutual antagonism between anterior and posterior PARs ensures their continued asymmetric localizations Cuenca et al., 2003; Etemad-Moghadam et al., 1995; Guo and Kemphues, 1995; Tabuse et al., 1998; Watts et al., 1996) .
Anterior PAR protein function is mediated through the kinase activity of PKC-3, which can phosphorylate PAR-1, PAR-2, and LGL-1 and drive their dissociation from the membrane (Beatty et al., 2010; Hao et al., 2006; Hoege et al., 2010; Hurov et al., 2004; Motegi et al., 2011) . PAR-3, PAR-6, and CDC-42 are all required for proper PKC-3 membrane localization (Gotta et al., A cue (purple) from the centrosome pair (black spheres) segregates aPARs into the anterior and promotes formation of a posterior PAR domain at the opposite pole (A, Establishment). PAR domains are then stable until cytokinesis (A, Maintenance) and drive polarization of cytoplasmic factors such as MEX-5/6 (green) and P granules (orange), which ensure the daughter cells acquire distinct fates (A, Two-cell). (B) Symmetry breaking can occur in two ways: (i) segregation of aPARs by cortical actomyosin flow (advection); and (ii) posterior PAR-2 loading. (C) A complex network of physical and regulatory interactions links the PAR proteins. Membrane binding (gray lines), physical interactions (black lines), as well as positive (/) and negative (t) feedback, are shown. Where links are indirect or unknown, dashed lines are used. Both CDC-42 and PAR-3 are required for stable membrane association of PAR-6/PKC-3. PAR-6 and PKC-3 depend on each other for membrane association. PAR-2, LGL-1, and presumably CHIN-1, are able to load onto the membrane independently. PAR-1 also binds membrane but requires PAR-2 to reach maximal concentrations. PKC-3 phosphorylates PAR-1, PAR-2, and LGL-1 and displaces them from the membrane. Exclusion of CHIN-1 from the anterior is dependent on PKC-3, but whether it is a direct target of PKC-3 is unknown. Together, PAR-1, via phosphorylation of PAR-3, and CHIN-1, by suppressing activated CDC-42, prevent invasion of the posterior domain by aPARs. PAR-3 and PAR-2 have been proposed to undergo oligomerization, which is thought to enhance their membrane association (noted by circular arrows). See recent reviews (Goehring, 2014; Hoege and Hyman, 2013; Motegi and Seydoux, 2013) 2001; Kay and Hunter, 2001; Schonegg and Hyman, 2006; Tabuse et al., 1998) . Consequently, loss of any of these four proteins results in identical zygote polarity phenotypes: posterior PAR proteins are found uniformly on the embryo membrane and the first cell division is symmetric, leading to cell fate defects and embryo lethality (Etemad-Moghadam et al., 1995; Kay and Hunter, 2001; Tabuse et al., 1998; Watts et al., 1996) . This similarity of aPAR mutant phenotypes, their co-segregation within the anterior domain, and their ability to interact with one another in a wide range of systems Joberty et al., 2000; Lin et al., 2000; Qiu et al., 2000) has led to consideration of an effective aPAR unit comprising PAR-3, PAR-6, PKC-3, and CDC-42. However, work across a range of cell types suggests that such minimalism belies significant complexity in the regulation of aPAR localization and function, which we are only beginning to decipher.
For example, in epithelia, PAR-3 and aPKC localize to distinct regions of the apical domain: PAR-3 is primarily junctional, while PAR-6 and aPKC are more apical and, together with CDC-42 and Crumbs, exclude PAR-1 and LGL from the apical domain (Betschinger et al., 2003; Harris and Peifer, 2005; Morais-De-Sa et al., 2010; Yamanaka et al., 2006; Yamanaka et al., 2003) .
In the C. elegans zygote, two modes of aPAR membrane association have been proposed: one associated with PAR-3 and independent of CDC-42, and one dependent on CDC-42 but not associated with PAR-3. Supporting this hypothesis, PAR-6 and PKC-3 only partially co-localize with PAR-3 in wild-type embryos, but co-localize strongly when CDC-42 is depleted Hung and Kemphues, 1999; Tabuse et al., 1998) . However, it remains unclear whether these observations reflect the existence of discrete functional modules and, if so, what their respective functions are.
A primary role of the aPAR network is to restrict PKC-3 kinase activity to the anterior domain. However, because localization, function, and regulation of PKC-3 are tightly coupled, parsing their individual contributions is difficult using traditional RNAi and knockout studies. Consequently, despite the central role of PKC-3 in polarity, we lack insight into how the individual contributions by PAR-3, PAR-6, CDC-42, and PKC-3 itself combine to ensure PKC-3 is activated only within the anterior domain. To address these questions, we require tools to independently modulate the localization and function of aPAR proteins.
Here we describe methods to independently manipulate PKC-3 activity and localization, which we use to investigate how PKC-3 kinase activity regulates organization of the aPAR network, and how PKC-3 activity is modulated by other network members. We find that localized PKC-3 kinase activity is linked to dynamic cycling of PAR-6/PKC-3 between two functionally distinct aPAR assemblies: (1) a PAR-3-dependent assembly that is associated with clusters and efficiently responds to polarizing cues, but in which PKC-3 activity is inhibited, and (2) a more diffuse CDC-42-dependent assembly that is less able to respond to polarizing cues but contains active PKC-3 and is responsible for posterior PAR protein exclusion. We propose that the dynamic exchange of PAR-6/PKC-3 between these two assemblies allows the PAR network to efficiently translate symmetrybreaking cues into an asymmetric homogeneous domain of PKC-3 activity.
RESULTS

Acute Inhibition of PKC-3 Function Leads to Loss of Asymmetric Division
We took two approaches to inhibit PKC-3 kinase activity. First, we examined a previously identified temperature-sensitive allele of pkc-3, ne4246 (Fievet et al., 2012) , which alters a conserved Asp residue (D386V) close to the active site. Strains carrying pkc-3(ne4246) are subsequently referred to as pkc-3(ts). Consistent with loss of PKC-3 function, in pkc-3(ts) zygotes at the restrictive temperature (25 C), PAR-2 is not restricted to the posterior membrane and is partitioned symmetrically into the two blastomeres at the first cell division ( Figure 1D ). Loss of asymmetry was quantified by the asymmetry index (ASI) (see STAR Methods), which measures the asymmetry of a feature, e.g., PAR-2 membrane intensity, relative to wild-type on a scale from zero (no asymmetry) to 1 (normal asymmetry) ( Figure 1D and Movie S1). Results below and in Figure S1 indicate that loss of asymmetry in pkc-3(ts) zygotes is due to loss of PKC-3 activity rather than degradation.
In parallel, we examined PKC-3 inhibitors in permeable, perm-1(RNAi) embryos (Carvalho et al., 2011) to identify compounds that yielded a PKC-3 deficient polarity phenotype. One compound, CRT0103390 (CRT90), a derivative of CRT0066854 ( Figures S2A-S2C ) (Kjaer et al., 2013; Dorsey et al., 2013) resulted in embryos that progressed normally through the cell cycle but showed loss of PAR-2 asymmetry and divided symmetrically ( Figure 1E and Movie S1). CRT90 embryos exhibited other common phenotypes associated with pkc-3(RNAi) and pkc-3(ts), including simultaneous division of the two daughter cells and ectopic spindle rotation in the anterior daughter cell, leading to a chain-like arrangement of cells in the 4-cell embryo (data not shown). As expected for an inhibitor of PKC-3 activity, CRT90 treatment caused loss of asymmetry in other posterior PAR proteins (PAR-1, LGL-1, and CHIN-1) as well as the loss of cytoplasmic asymmetry in the cell fate determinants PIE-1 and MEX-5 ( Figure 1F ).
PKC-3 Inhibition Yields Distinct Phenotypes from PKC-3 Depletion
We next investigated the distributions of the anterior PAR proteins when PKC-3 activity was inhibited, and compared these to those observed when PKC-3 was depleted by RNAi. Normally, PAR-3, PAR-6, and PKC-3 are efficiently segregated into the anterior during the polarity establishment phase and remain asymmetric until cytokinesis (Cuenca et al., 2003) . When PKC-3 is depleted by RNAi of pkc-3, PAR-6 fails to localize to the membrane (Figure 2A ) (Hung and (F) Midsection (PAR-1, LGL-1, PIE-1, MEX-5) or cortical (CHIN-1) fluorescent images of maintenance-phase zygotes expressing markers to various downstream polarity markers in DMSO (control), CRT90-treated, and pkc-3(RNAi). Asymmetry in (D) to (F) is quantified by the asymmetry index, with one being normal asymmetry and zero, no asymmetry (ASI, normalized to DMSO/WT controls). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Scale bars, 10 mm. See also Figures S1 and S2; Movie S1. (DMSO, ) conditions. PAR-6 (A and B) and show loss of asymmetric membrane staining in PKC-3-inhibited zygotes at both establishment and maintenance phase (posterior localization indicated by white arrowheads). In pkc-3(RNAi), PAR-6 is absent from the membrane at all times. PAR-3 (E and F) still polarizes in PKC-3-inhibited zygotes, but becomes weaker and less asymmetric during maintenance phase. Note that (B), (D), and (F) show the same wild-type and TS zygotes with the PAR-3 boundary position in TS indicated (red arrowheads) to allow comparison: PAR-6 and PKC-3 are clearly visible at the posterior membrane (white arrowheads), while PAR-3 is undetectable, as in wild-type. Bright foci in (D) are non-specific centrosome staining. (G and H) Normalized ASI measurements for late establishment phase datasets represented in (A) to (F). ASI is normalized to control (wild-type [WT] or DMSO) for each protein.
(I and J) Anterior to posterior membrane distributions of PAR-3 (red) and PKC-3 (black) in wild-type (I) and pkc-3(ts) (J) embryos. Arrows highlight the posterior extension of PKC-3 relative to PAR-3. Mean ± SD is shown.
(legend continued on next page) Kemphues, 1999) . By contrast, PAR-3 remains membrane associated and segregates into the anterior, but this population is generally reduced compared to wild-type and is lost as the cell proceeds through mitosis ( Figure 2E ) .
Unlike pkc-3(RNAi), when PKC-3 is inhibited by the D386V mutation or CRT90, PAR-6 and PKC-3 remain membrane associated, fail to segregate efficiently to the anterior, and a significant pool of both proteins remains localized at the posterior pole resulting in a loss of asymmetry relative to controls (Figures 2A-2D , 2G, and 2H; Movie S2). In contrast to PAR-6 and PKC-3, PAR-3 still segregates into the anterior during the establishment phase in PKC-3-inhibited zygotes (Figures 2E and 2F, Establishment) . The domain is typically somewhat enlarged relative to wild-type zygotes, but PAR-3 asymmetry remains high and PAR-3 is absent from the posterior pole ( Figures 2G and 2H) . Following the establishment phase, PAR-3 levels at the membrane decline and become more symmetric (Figures 2E and 2F, Maintenance) .
The distinct response of PAR-3 versus PAR-6 and PKC-3 is particularly clear in the quantification of dual-labeled fixed zygotes. In wild-type zygotes, the boundaries of the PAR-3 and PKC-3 domains are positioned similarly at the center of the zygote, although the PKC-3 domain extends a few microns further into the posterior ( Figures 2I and 2K , WT). By contrast, in PKC-3-inhibited embryos, PKC-3 extends significantly further into the posterior compared with PAR-3, a condition we refer to as ''decoupled'' ( Figures 2J-2L , TS). Consistent with this decoupling, upon PKC-3-inhibition we observe a decrease in co-localization between PAR-3 and PAR-6 at the membrane/cortex, even in the anterior domain where these PAR proteins overlap ( Figure S3 ). Thus, we conclude that PKC-3 is required for the normally tight coupling between PAR-6/PKC-3 and PAR-3 during symmetry breaking.
These results point to an unappreciated complexity in the assembly and regulation of the PAR proteins at the cell membrane:
First, the loss of membrane-associated PAR-6 in PKC-3-depleted zygotes, but not in PKC-3-inhibited zygotes (Figure 2A) , shows that disruption of PKC-3 activity or the resulting invasion of pPARs into the anterior ( Figures 1D-1F ) do not account for loss of PAR-6 membrane association. Rather, there appears to be a requirement for PKC-3 protein itself to target and stabilize PAR-6 at the membrane. Consistent with this interpretation, mutations in par-2 and par-1 fail to rescue PAR-6 membrane localization in pkc-3(RNAi) zygotes ( Figure S4 ).
Second, in PKC-3-inhibited zygotes, anterior and posterior PAR protein distributions on the membrane overlap ( Figure 2M ). Posterior PAR proteins are thought to directly antagonize the ability of anterior PAR proteins to associate with the membrane, yet in these zygotes aPARs appear resistant to pPAR antagonism. PKC-3 inhibition could conceivably affect the activity of posterior PARs. However, we found that PAR-1 kinase activity, as measured by MEX-5 mobility , appears normal in PKC-3-inhibited zygotes ( Figures S2D-S2F ). Thus, PKC-3 activity appears necessary to render anterior PARs sensitive to the antagonistic effects of posterior PARs, challenging the simple paradigm of mutual antagonism, which would predict pPAR dominance.
Finally, decoupling of PAR-6/PKC-3 from PAR-3 localization in PKC-3-inhibited zygotes during symmetry breaking suggests that PKC-3 drives formation of distinct PAR complexes or assemblies during polarity establishment in the C. elegans zygote. Contrary to what has been observed in Drosophila epithelia, where aPKC activity promotes decoupling of PAR-3 from PAR-6/aPKC and their targeting to distinct sites (Morais-De-Sa et al., 2010), here we observe the opposite: PKC-3 kinase activity is implicated in coupling the behaviors of PAR-3 and PAR-6/ PKC-3, allowing their coordinated segregation during symmetry breaking.
PKC-3 Inhibition Promotes PAR-3-Independent
Formation of CDC-42-Dependent PAR-6/PKC-3 Assemblies If PKC-3 inhibition favors formation or trapping of a distinct functional assembly, we reasoned that it might affect the normal dependencies of PAR-6 and PKC-3 on PAR-3 and CDC-42. PKC-3 and PAR-6 normally require both PAR-3 and CDC-42 to localize stably to the membrane Sailer et al., 2015) . The dependency on PAR-3 is stronger: PKC-3 and PAR-6 fail to localize to the membrane in PAR-3-depleted zygotes (par-3(RNAi) in Figures 3A-3F) . By contrast, in CDC-42-depleted zygotes, PKC-3 and PAR-6 initially localize to the membrane and segregate to the anterior, but their membrane localization is gradually lost during the maintenance phase, becoming weaker and more uniform as zygotes approach cytokinesis (cdc-42(RNAi) Figures 3A-3F and Movie S4) Gotta et al., 2001; Motegi and Sugimoto, 2006; Sailer et al., 2015; Schonegg and Hyman, 2006) . Importantly, depletion of PAR-1 or PAR-2, which invade the anterior in the absence of PAR-3 or CDC-42 (Etemad- Moghadam et al., 1995; Gotta et al., 2001; Kay and Hunter, 2001; Schonegg and Hyman, 2006) , fails to rescue PAR-6 membrane localization in these conditions ( Figure S4 ). Thus, both PAR-3 and CDC-42 are directly required to promote membrane association of PAR-6 and PKC-3.
We find that under conditions of PKC-3 inhibition (D386V or CRT90), PKC-3 and PAR-6 no longer depend on PAR-3 to localize to the membrane (Figures 3A-3F and S5A; Movies S3 and S4). The degree of localization varies between the two methods of PKC-3 inhibition, possibly reflecting differences in the mechanism or timing/kinetics of kinase inhibition. By contrast, CDC-42 is still required for PKC-3 and PAR-6 membrane localization in PKC-3-inhibited zygotes (Figures 3A-3F, S5A, and S5B; Movie S4), indicating that CDC-42 is still required for PAR-6/PKC-3 membrane targeting even when PKC-3 is inhibited. Consistent with previous work showing that Cortical Intensity (a.u.)
GFP::PKC-3 PAR-6::GFP (legend continued on next page) PAR-6/aPKC are typically associated with an active, guanosine triphosphate (GTP)-bound form of CDC-42 (Atwood et al., 2007; Gotta et al., 2001; Joberty et al., 2000; Lin et al., 2000; Qiu et al., 2000) , we found that decreasing CDC-42/GTP by depletion of the CDC-42 GEF, CGEF-1, reduces membrane association of PAR-6/PKC-3 in pkc-3(ts) embryos compared with wild-type, while leaving PAR-3 levels unchanged . Finally, PKC-3 remains dependent on PAR-6 in PKC-3-inhibited embryos, consistent with PAR-6 being required to mediate the interactions of the PAR-6/PKC-3 heterodimer with PAR-3 and/or CDC-42 ( Figures 3A and 3D-3F ; Movie S4) (Joberty et al., 2000; Qiu et al., 2000) , as well as our general findings that PKC-3 and PAR-6 respond similarly in all assays described. Thus, inhibition of PKC-3 activity allows PKC-3 to bypass its normal requirement on PAR-3 to load onto the membrane and form stable membrane-associated CDC-42/GTP-dependent complexes. We postulate that it is this dependency on PAR-3, enforced by PKC-3 kinase activity, that ensures the coupled distributions of PKC-3 and PAR-3 in the embryo.
Segregation of Anterior PAR Proteins Is Associated with PAR-3-Dependent Clustering at the Membrane So far, we have shown that inhibition of PKC-3 kinase activity promotes CDC-42-dependent assemblies, and in so doing prevents PKC-3 and PAR-6 from segregating efficiently with PAR-3 into the anterior during symmetry breaking. Previous work has shown that the efficient segregation of anterior PAR proteins is due to advective transport by anteriorly-directed actomyosin cortical flow (Cheeks et al., 2004; Goehring et al., 2011b; Munro et al., 2004) . Because PAR-3 continues to be segregated efficiently in PKC-3-inhibited zygotes, we reasoned that PKC-3 inhibition may selectively alter the molecular organization of PAR-6 and PKC-3 at the membrane relative to PAR-3, which would be consistent with the observed shift toward CDC-42-dependent PKC-3 assemblies.
To investigate these possibilities, we imaged PAR-3, PAR-6, and PKC-3 at the membrane using variable-angle epifluorescence microscopy (VAEM or pseudo-TIRF) (Konopka and Bednarek, 2008) . All three proteins exhibit a distinct clustered appearance during the polarity establishment phase, consistent with reports of non-homogenous distributions of PAR proteins at the membrane (Figures 4A and 5A, Establishment) (Munro et al., 2004; Robin et al., 2014; Sailer et al., 2015) . Similar to previous analysis of PAR-6 (Munro et al., 2004) , we find that clusters of PAR-6, PAR-3, and PKC-3 move in a highly directional manner in the direction of cortical flow, coinciding with increasing overall asymmetry ( Figure 4B and Movie S5). While aPAR clusters have been noted (Hung and Kemphues, 1999; Munro et al., 2004; Sailer et al., 2015) , the relationship between clustered and non-clustered PAR proteins and their ability to segregate in response to flow has not been explored.
To test whether clustering is a key driver of aPAR segregation, we examined whether PAR-3 transport depends on its ability to cluster. PAR-3 contains a conserved CR1 oligomerization domain, which is required for membrane binding and is targeted by PAR-1 kinase to induce displacement form the membrane (Benton and St Johnston, 2003; Feng et al., 2007; Li et al., 2010; Mizuno et al., 2003) . We reasoned that this domain would be required for clustering; however, because mutations in the CR1 domain disrupt membrane binding ( Figure 4D , WT versus DCR1), assessing clustering and segregation of a PAR-3DCR1 mutant requires an alternative mode of membrane targeting. We restored membrane localization of GFP:PAR-3DCR1 using a membrane-tethered anti-GFP nanobody (PH-GBP) and compared this with the behavior of GFP:PAR-3 (wild-type) that was also tethered to the membrane via PH-GBP. Targeting both wild-type and DCR1 to the membrane with PH-GBP reduces potential confounding effects of PAR-1-induced membrane displacement in the posterior. Thus, differences in segregation in PAR-3DCR1 relative to wild-type should be due to changes in clustering rather than differential sensitivity to PAR-1.
Consistent with oligomerization being required for clustering, membrane-tethered PAR-3DCR1 exhibited more diffuse membrane localization compared with wild-type controls ( Figures  4D and 4E , WT + GBP versus DCR1 + GBP). PAR-3DCR1 also showed reductions in both segregation into the anterior and overall asymmetry ( Figures 4F-4H and Movie S5). Thus, the ability of the CR1 domain to drive formation of membrane-associated PAR-3 clusters ensures that PAR-3 is efficiently transported by cortical flows in addition to its known role in promoting membrane association.
Balance between PAR-3 and CDC-42 Assemblies Tunes Cortical Organization and Sensitivity to Cortical Flow
The correlation between lack of PAR-3 clustering and defects in advective transport prompted us to examine the organization of anterior PAR proteins at the membrane in more detail. Although PAR-6 and PKC-3 exhibit a distinct clustered appearance similar to PAR-3 during polarity establishment, clusters are less pronounced and accompanied by a background of a more diffuse population ( Figures 4A, 4C , and 5A). By contrast, CDC-42 exhibits a more uniform signal overall that resembles typical membrane markers, such as the PIP 2 (phosphatidylinositol-4,5-bisphosphate) probe PH-PLCD1 ( Figures 4A and 4C) . Membrane markers do exhibit enriched signals in membrane folds and protrusions, which are also enriched in the anterior, but these signals are clearly distinguishable from clusters.
With the transition into maintenance phase, clusters of PAR-6 and PKC-3 become less prominent and a diffuse population dominates. This change coincides temporally with a decrease in the prominence of PAR-3 clusters and an overall reduction in PAR-3 membrane localization ( Figures 4A and 4C ) as well as an increase in anterior CDC-42 activity ( Figures S5C-S5E ) (Kumfer et al., 2010) . We therefore speculated that the mix of diffuse and clustered PAR-6/PKC-3 observed during establishment phase may reflect the distinct CDC-42-and PAR-3-dependent assemblies that we describe above. Consequently, cell-cycle-dependent changes in the balance between assembly types could effectively tune the system to promote efficient transport of aPAR species during the polarity establishment phase.
To test this hypothesis, we altered the balance between CDC-42-and PAR-3-dependent assemblies and monitored the corresponding changes in (1) organization at the membrane, and (2) segregation efficiency. In general, we find a striking correlation between quantitative measures of cortical clustering and overall asymmetry.
Depletion of CDC-42 is known to increase co-localization of PAR-6 with PAR-3 during polarity establishment . We find that this also increases overall clustering of PAR-6 (Figures 5A and 5B) . Examination of PKC-3 distributions clearly reveals enhanced segregation, with increased ASI ( Figure 5C ) and a visibly steeper domain boundary that is shifted toward the anterior ( Figure 5D ), resulting in a smaller anterior domain (*p < 0.01). Consistent with these data, we also observe a tighter coupling between the PAR-3 and PKC-3 domain boundaries in dual-labeled fixed zygotes ( Figure 5K ).
In contrast to CDC-42 depletion, inhibition of PKC-3 using CRT90, which favors CDC-42-dependent assemblies, shows reduced clustering of PAR-6, which could be reduced further by also depleting PAR-3 ( Figures 5A and 5B ). Under these conditions that favor CDC-42-dependent assemblies and reduced clustering, PKC-3 segregated less efficiently than DMSO controls, exhibited a reduced ASI, and failed to be fully excluded from the posterior ( Figures 5C and 5D ). To confirm that this reduction in clustering and segregation is due to favoring CDC-42-dependent assemblies, we examined the effect of expressing CDC-42 (Q61L), which stabilizes the active GTP-bound form of CDC-42 (Aceto et al., 2006; Ziman et al., 1991) . Unlike PKC-3 inhibition, CDC-42 (Q61L) does not efficiently bypass the normal dependence of PKC-3 on PAR-3 ( Figures S5F-S5J ). This suggests that inhibition of PKC-3 favors CDC-42-associated assemblies via a mechanism distinct from stabilizing the GTP-bound form of CDC-42. However, similar to what we see when PKC-3 is inhibited, expression of CDC-42 (Q61L) reduced clustering and resulted in less efficient segregation of PKC-3 (Figures 5F-5K) . Thus, regardless of the mechanism by which we alter the balance between PAR-3-and CDC-42-dependent assemblies, we achieve similar effects on clustering and segregation. This is particularly striking when we plot mean cluster index versus asymmetry across all conditions at establishment phase ( Figure 5E ).
Because PAR proteins are known to regulate actomyosin dynamics (Cheeks et al., 2004; Munro et al., 2004) , and changes in flow velocities could, in principle, affect advective transport (Goehring et al., 2011b) , we wanted to confirm that clustering rather than potential changes in flow velocity were the cause of reduced segregation efficiency. Measurements of flow rates from yolk granule motion in differential interference contrast (DIC) images allowed us to test the relationship between cortical flow rates and asymmetry in individual zygotes. Consistent with anterior PARs promoting their own segregation via stimulation of cortical flows, we find that PKC-3 inhibition results in a reduction of flow rates from approximately 6-10 mm/min in controls to approximately 2-5 mm/min in CRT90-treated embryos (Figure 5L) . To test whether alterations in flow velocities could account for the observed segregation defects, we performed a partial depletion of MLC-4 to generate embryos with flow velocities of a similar range as observed in PKC-3-inhibited embryos ( Figure 5L ). Despite a similar range of flow velocities, MLC-4-depleted zygotes show a minimal reduction in asymmetry versus controls ( Figures 5M and S6A ). Plotting flow velocity versus ASI reveals a weak decline in ASI as flow rates are reduced (Figure 5N) . By contrast, CRT90-treated embryos show a lower ASI across the full range of observed flow rates ($2-5 mm/min, Figures 5N and S6A) . Finally, to test whether restoring flows could rescue efficient segregation of PKC-3, we used RNAi to target the RhoGAPs, RGA-3/4, which results in excess actomyosin contractility and increased cortical flow rates (Fievet et al., 2012; Schonegg et al., 2007) . Despite fully rescuing the moderate reduction in asymmetry of PAR-3 observed in pkc-3(ts) embryos to levels indistinguishable from wild-type, RGA-3/4 depletion failed to restore asymmetry of PKC-3 ( Figures S6B  and S6C ).
Together these data suggest that it is the failure of PKC-3 to associate with clusters rather than changes in flow rates that are the dominant factor in the decoupling between the localization of PAR-3 and PAR-6/PKC-3 observed in PKC-3-inhibited embryos. In fact, the resilience of PKC-3 asymmetry in embryos partially depleted of MLC-4 suggests that there is a relatively low threshold velocity required for efficient segregation of aPAR proteins by cortical flow, provided aPARs are able to associate normally into clusters.
We therefore conclude that although both PAR-3 and CDC-42 are critical for normal PAR-6/PKC-3 localization at the membrane in wild-type embryos, they drive formation of distinct aPAR assemblies, with distinct physical properties and (E) Combining clustering data from pseudo-TIRF imaging in (A) and (B) and (F) and (G) with ASI measurements of a complete GFP::PKC-3 dataset for lateestablishment phase across all conditions allows us to plot cluster index versus ASI for the mean of each condition, revealing a strong correlation (linear regression: R 2 = 0.85, p < 0.01). responsiveness to cortical flow: PAR-3-dependent assemblies exhibit pronounced clustering, at least during the establishment phase, and are efficiently segregated by cortical flow. By contrast, CDC-42-dependent assemblies are more diffuse, likely reflecting enhanced diffusional mobility, and are inefficiently segregated by flow. Importantly, the balance between these two species appears to be subject to cell-cycle-dependent regulation to ensure maximal clustering and transport during the period of peak actomyosin cortical flows.
A PKC-3 Membrane-Targeting Assay Reveals Opposing Roles for PAR-3 and CDC-42 in Regulating PKC-3 Activity We next sought to explore whether there were other functional differences in these two types of assemblies. Specifically, we wondered whether PAR-3 and CDC-42 may have distinct regulatory effects on PKC-3 activity in vivo, which is difficult to analyze given their roles in PKC-3 membrane loading. While CDC-42 is generally thought to play an activating role (Atwood et al., 2007; Gotta et al., 2001; Joberty et al., 2000; Lin et al., 2000; Qiu et al., 2000) , the roles for PAR-3 and PAR-6 are less clear and may vary in different contexts (Achilleos et al., 2010; Atwood et al., 2007; David et al., 2013; Graybill et al., 2012; Lin et al., 2000; McCaffrey and Macara, 2009; Wirtz-Peitz et al., 2008) . To directly assess whether PKC-3 activity differs in PAR-3-associated and CDC-42-associated assemblies in vivo, we targeted PKC-3 to the membrane by fusing it to the C1B domain of human PKCa, which can be induced to bind the membrane by the addition of phorbol ester ( Figure 6A ) (Lekomtsev et al., 2012) . This bypasses the membrane-binding requirement of PKC-3 on PAR-3, PAR-6, and CDC-42, allowing us to test their contribution to PKC-3 activity by monitoring membrane removal of the PKC-3 target, PAR-2.
In the absence of phorbol ester, C1B-PKC-3 mirrors endogenous PKC-3 localization and is anteriorly enriched, with PAR-2 restricted to the posterior as in wild-type ( Figure 6B , No PMA). Upon addition of 100 mM phorbol 12-myristate 13-acetate (PMA), C1B-PKC-3 is recruited uniformly to the membrane and the PAR-2 domain shrinks, consistent with an increase in posterior PKC-3 activity (Figure 6B , +PMA; Figure 6C ; Movie S6). The reduction in PAR-2 domain size is not seen in the absence of PMA, when targeting the C1B domain alone to the membrane, or if we inhibit PKC-3 with CRT90 ( Figures 6B and 6D) . The failure to completely remove PAR-2 in polarized zygotes is not simply due to PAR-2 being concentrated in a domain, because ectopic PAR-2 domains that form in meiotic arrest mutants, e.g., mei-1 and emb-27 (Wallenfang and Seydoux, 2000) , are rapidly cleared ( Figure S7 ).
In zygotes, both endogenous PKC-3 and the C1B-PKC-3 fusion are cytoplasmic in the absence of PMA, allowing PAR-2 to localize uniformly to the membrane ( Figures 6E and 6F) . In par-6 and cdc-42(RNAi) zygotes, membrane targeting of C1B-PKC-3 (+PMA) has no effect on PAR-2 distribution: it remains uniformly enriched at the membrane with no difference compared with controls in which C1B alone is targeted to the membrane (Figures 6E and 6F ; Movie S7). Thus, both PAR-6 and CDC-42 are required for PKC-3 activity in vivo.
By contrast, membrane targeting of C1B-PKC-3 in par-3(RNAi) zygotes induces rapid loss of PAR-2 from the membrane, with near complete removal within minutes (Figures 6E  and 6F ; Movie S7). The displacement of PAR-2 is stronger than in wild-type zygotes, suggesting that PAR-3 normally acts to inhibit or suppress PKC-3 activity ( Figure 6B, +PMA) . Thus PAR-3 has two roles in vivo: it promotes PKC-3 membrane targeting while at the same time limiting its activation, reconciling in vivo reports whereby PAR-3 positively regulates PAR polarity (Achilleos et al., 2010; McCaffrey and Macara, 2009 ) with data indicating that PAR-3 can inhibit PKC-3 activity in vitro (Graybill et al., 2012; Lin et al., 2000; Soriano et al., 2016) .
DISCUSSION
Taken together, our data suggest that efficient polarization requires PKC-3 to cycle between functionally specialized modules of the anterior PAR network: a PAR-3-dependent module that segregates in response to symmetry-breaking signals, but which is inactive, and a CDC-42-dependent module that uses spatial information provided by PAR-3 to create an anterior domain of PKC-3 activity on the membrane (Figure 7) .
In previous work, we showed that the diffusion and membrane dissociation rates of aPARs were in principle sufficient to explain segregation in response to flows (Goehring et al., 2011b ). Here we show that segregation of aPARs is directly linked to PAR-3-dependent clustering. Clustering reduces the effective diffusion of membrane-associated aPARs, which should favor advective transport. Alternatively, the sheer size of clusters may allow them to sense flow that would not affect individual proteins, possibly by allowing them to extend into the cortical actomyosin layer. Regardless of the physical mechanism, as we show here, clustering drives robust segregation of PAR-3 by cortical flow. This fact, coupled with PAR-3 exclusion from the posterior by PAR-1-dependent phosphorylation (Motegi et al., 2011 ), supports a model in which PAR-3 is responsible for sensing asymmetry-generating cues. Importantly, once it is asymmetric, PAR-3 provides a landmark for polarized loading of PAR-6/PKC-3, explaining recent observations that PAR-6 loads preferentially in the anterior of polarized embryos (Sailer et al., 2015) .
Because our in vivo PKC-3 activity assay indicates that PKC-3 activity is suppressed within PAR-3-dependent assemblies, PAR-6/PKC-3 molecules must be converted into an activated CDC-42-dependent species, a state that we show is non-clustered and diffusive. Whereas this diffusive behavior of CDC-42-assemblies is a disadvantage for transport by cortical flow, it is an advantage for creating a uniform, wider-range field of PKC-3 activity that can efficiently exclude pPARs. If the same complexes had to respond to flow and exclude pPARs, there would be a trade-off between efficiency of transport by flow and uniformity of pPAR inhibition at the anterior.
For this field of activated CDC-42-dependent PKC-3 assemblies to remain coupled to the spatial information provided by PAR-3, two conditions must be satisfied. First, PKC-3 membrane localization must be dependent on PAR-3, and second, diffusion of CDC-42-associated PKC-3 away from loading sites must be limited, with PKC-3 ultimately being released back into the cytoplasm, where it again becomes dependent on PAR-3. This turnover restricts the effective distance these (B) Zygotes expressing GFP::C1B alone (GFP::C1B-Ø) or GFP::C1B-PKC-3 along with mCherry::PAR-2 were subject to the indicated treatment. Note that uniform membrane targeting of C1B-PKC-3 leads to reduction of PAR-2 domain size, whereas omitting PMA or expressing C1B alone has no effect. Right: cartoon representation of results.
(C) Quantification of PAR-2 domain size ratio for embryos shown in (B).
(D) PAR-2 retention in GFP::C1B-PKC-3 expressing zygotes treated with PMA and CRT90 confirms that induced PAR-2 loss is dependent on PKC-3 kinase activity.
(E) Zygotes expressing mCherry::PAR-2 with GFP::C1B-Ø or GFP::C1B-PKC-3 subject to par-6, cdc-42, or par-3(RNAi) before and 5 min after PMA addition.
(F) Quantification of PAR-2 cortex retention comparing GFP::C1B-PKC-3 and GFP::C1B-Ø zygotes after treatment with PMA as in (E). Representative midsection confocal images are shown in (B), (D), and (E) before and 5 min after PMA/DMSO addition. ***p < 0.001. ns, not significant. Scale bars, 10 mm. See also Figure S7 ; Movies S6 and S7.
complexes can diffuse from their initial sites of formation, defining an effective ''sphere of influence'' around PAR-3 loading sites. Together, these requirements result in a cycle of localized membrane loading, activation, and release ( Figure 7 ). Our data suggest that the first of these requirements, PAR-3-dependent loading, is dependent on the kinase activity of PKC-3 itself, although the precise mechanism is unclear. Given the limited ability of CDC-42 (Q61L) to rescue PKC-3 membrane localization in PAR-3-depleted embryos, PKC-3 is likely to act at the step of CDC-42 complex generation, either inhibiting its own association with CDC-42, and/or destabilizing nascent CDC-42/PAR-6/PKC-3 assemblies. We speculate that it could be the very act of inhibiting PKC-3 through which PAR-3 promotes generation of stable CDC-42-dependent assemblies, but further work will be required to reveal the details of this molecular handover. Because the inhibitory role of PAR-3 appears to be broadly conserved (David et al., 2013; Graybill et al., 2012; Lin et al., 2000; Soriano et al., 2016) , this apparent paradoxical role of PAR-3 in promoting formation of membrane-associated aPKC complexes, yet also suppressing PKC-3 activity, may be a general feature of aPKC regulation.
How diffusion of CDC-42-associated PKC-3 is limited also remains unclear. Measurements elsewhere suggest that the distance these activated assemblies travel is on the order of 5-10 mm Robin et al., 2014) , consistent with the PKC-3 gradient extending further into the posterior than PAR-3 during the establishment phase even in wild-type (ii) Clustering of membrane-associated PAR-3 allows it to be segregated by cortical flow into the anterior, carrying along associated PKC-3 molecules and generating asymmetric sites for further PKC-3 loading. (iii) PKC-3 activation requires conversion into a CDC-42-associated assembly, which relieves inhibition of PKC-3 by PAR-3. (iv) The CDC-42-dependent module is freely diffusible on the membrane and locally excludes pPARs. (v) Dissociation of CDC-42-dependent assemblies limits the spread of active PKC-3 at the membrane from the PAR-3 recruiting site. (vi) PKC-3 returns to the cytoplasm where it must load again via PAR-3.
embryos (see Figure 2I ). Because CDC-42 assemblies appear to be resistant to removal by posterior PAR proteins ( Figure 2M ), including the CDC-42 GAP CHIN-1, it seems likely that it is not preferential removal of these complexes in the posterior by pPARs, but rather the intrinsic lifetime of CDC-42-dependent PKC-3 assemblies that limits their diffusion into the posterior. This is compatible with a model in which aPKC undergoes asymmetric membrane loading but symmetric dissociation (Robin et al., 2014) .
By loading PKC-3 via what we presume is an inhibited PAR-3-associated state, which must then be activated, PKC-3 localization and activation are segregated into distinct modules of the PAR network, which can be regulated independently. This division of labor may be critical for PAR proteins, which operate across diverse contexts, where the polarity cues, substrates, scales, and even the concentrations of PAR molecules themselves may vary substantially. Even within the C. elegans zygote, the mechanisms of PAR segregation vary. During polarity establishment, when cortical flow is the major cue for anterior PAR segregation, PAR-3 clustering is prominent (Cheeks et al., 2004; Goehring et al., 2011b; Munro et al., 2004) . As the system enters the maintenance phase, flow ceases and continued aPAR segregation becomes dependent on the activity of PAR-1 and CHIN-1 (Beatty et al., 2013; Guo and Kemphues, 1995; Kumfer et al., 2010; Sailer et al., 2015) . Notably, clustering appears to be reduced during this phase, which Dickinson et al. (2017) show is dependent on PLK-1. This change in PAR molecular organization potentially reflects the shift in the spatial signals to which the PAR network must respond. At the same time, despite these changes, PKC-3 activity must remain efficient at displacing pPARs from the anterior domain, highlighting the adaptability of the PAR network.
In summary, here we have identified a critical role for the separation of signal-receiving and signal-transducing functions between modules of the aPAR network that are distinct, but coupled via dynamic exchange of the shared signaling component, PKC-3. We suggest that functional specialization of coupled modules resolves potential molecular constraints between components that must be sensitive to polarity cues and those that must propagate the signals. It further allows the system to independently modulate responsiveness to cues as well as the extent and strength of the output signal. The adaptability of such a paradigm suggests it is likely to be a common strategy in patterning systems.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (pC1B-Ø) using SpeI and StuI to generate pC1B-pkc-3. Both plasmids were introduced by biolistic bombardment into HT1593 worms (Praitis et al., 2001) , yielding NWG0012 and NWG0016.
The membrane-tethered GFP-binding protein (PH-GBP) was generated by combining amino acids 1-175 corresponding to the PH domain of rat PH-PLCD1 (Audhya et al., 2005) and VHH4GFP (Caussinus et al., 2011) coupled by a SGQGGSGGSGGS linker. The resulting sequence was codon-optimized (CAI = 0.49) and a single GFP intron inserted as described (Redemann et al., 2011) . A synthetic gBlock (IDT DNA) encoding the PH-GBP was PCR amplified and cloned in frame with a C-terminal codon-optimized mKate2 under the control of the mex-5 promoter and nmy-2 3' UTR in a MosSCI vector containing wild-type unc-119 obtained from the Hyman Lab. The resulting plasmid (pNG0018) was inserted at the ttTi5605 mos1 site locus of DP38 worms via CRISPR after mutating the sgRNA/PAM site following the method described (pNG0019) (Dickinson et al., 2013) . Modified worms were crossed into DR466 to generate a stable male line expressing PH-GBP (NWG0047). To rescue membrane localization of PAR-3 variants, we crossed NWG0047 with KK1216 (par-3::gfp) or KK973 (par-3Dcr1::gfp) lines. We were unable to obtain a stable homozygous line for the endogenously tagged PAR-3::GFP, presumably due to the toxic effects of continuously targeting all PAR-3 to the membrane throughout embryogenesis. Thus, we used F1 progeny heterozygous for PAR-3::GFP for analysis. By contrast, for PAR-3DCR1::GFP, which is expressed ectopically from a multi-copy random insertion, we readily obtained animals homozygous for both PAR-3DCR1::GFP and PH-GBP, which were used for subsequent analysis. However, no significant difference in the segregation of PAR-3DCR1::GFP was seen between heterozygous and homozygous animals.
For analysis of GFP::CDC-42, SA131 was used unless otherwise indicated. For analysis of the effects of CDC-42(Q61L) on GFP::PKC-3 localization, zygotes were taken from F1 animals resulting from crossing KK1228 with either TH159 or WH423 due to difficulties obtaining stable animals homozygous for both markers.
Cell Lines HEK-293 are female and were obtained from Cell Production, Cancer Research UK (CRUK) and cultivated in DMEM (Dulbecco's modified Eagle's medium), 10% FBS (fetal bovine serum) and penicillin-streptomycin (Invitrogen) (Kjaer et al., 2013) .
Bacterial Strains OP50 bacteria and HT115(DE3) were obtained from CGC. DH5a was obtained from Colin Dolphin. Feeding by RNAi used HT115(DE3) bacteria strains containing a plasmid carrying the indicated RNAi feeding plasmid.
METHOD DETAILS
C. elegans -RNAi Culture Conditions RNAi by feeding was performed similar to described methods (Kamath et al., 2003) . Briefly, HT115(DE3) bacterial feeding clones were inoculated from LB agar plates to LB liquid cultures and grown overnight at 37 C in the presence of 10 mg/ml carbenicillin. Bacterial cultures were induced with 5 mM IPTG at 37 for 4h with agitation before spotting 100 ml of induced bacteria onto 60 mm agar RNAi plates (10 mg/ml carbenicillin, 1 mM IPTG). L4 larva were added to RNAi feeding plates and incubated for 24-72 hr depending on gene and temperature. For temperature sensitive lines, feeding was performed at 15 C for 48-72 hr and shifted to 25 C for 2-5 hr before imaging. For double depletion experiments, L3/L4 larva carrying par-1(zu310) or par-2(it5) temperature sensitive mutants were placed on RNAi plates at 15 C for 24 hr before a fraction of those were moved to fresh RNAi expressing plates for 18 to 22 hr at 25 C. Partial RNAi for mlc-4 was performed for 14-24 hr at 20 C. For partial depletion of perm-1, rga-3/4 or pkc-3, bacteria expressing the desired clone were mixed at the indicated ratios with bacteria expressing control clones are from the Ahringer library (Kamath et al., 2003) . mlc-4 is from Redemann et al., 2010 . A control RNAi clone was generated by synthesizing a random 500bp sequence using the Matlab random number generator with no homology to the worm genome, cloned into Bgl-II / HindIII sites of L4440 (Addgene, plasmid#1654), and transformed into HT115 bacteria.
C. elegans Embryos -Western Blots
Embryos were obtained by a standard bleaching protocol and resuspended in NuPAGE LDS sample buffer (Invitrogen) prior to sonication using the Biorupture (Diagenode) for 5 -30 s on, 30 s off cycles. Samples were heated at 70 C for 10 min before centrifugation at 13.000 rpm for 20 min to obtain cleared supernatant. Samples were run on a 12% NuPAGE gel using MOPS SDS running buffer (Invitrogen) and transferred onto PVDF membrane (Immobilon-P membrane 0.45 um, Millipore). PKC-3 and tubulin was detected using the primary (anti-PKC-3 1:10.000 and anti-tubulin 1:20.000) and secondary antibodies (as recommended by provider) indicated in Key Resources Table and detected via chemiluminescence (ECL prime, GE Healthcare Life Sciences). PKC-3 band intensity was analyzed using the Fiji Gel analysis tool.
C. elegans Zygotes -Drug Treatment All drug treatment experiments were performed in 10 to 50% perm-1(RNAi) (Carvalho et al., 2011) . Drugs were dissolved in DMSO and used at the following concentrations: phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich, P1585-1MG), 100 mM; CRT90 (CRT0103390, Cancer Research Technology LTD), 10 mM. When drug treatment alone was required, we obtained zygotes with permeable eggshells by placing L4 animals on a 1:1 mix of bacteria expressing perm-1(RNAi) and ctl (RNAi) for 16 to 20 hr at ice-cold Tris lysis buffer [150 mM NaCl, 20 mM Tris (pH 7.5), 1 mM EGTA, 1 mM EDTA and 1% Triton X-100]. Lysates were transferred on to an anti-FLAG-coated ELISA plate (Sigma) and incubated for 2 hr with gentle shaking, followed by an automated wash step (Tecan plate washer) with wash buffer [50 mM Tris (pH 7.5), 0.15 M NaCl and 0.02% Tween 20]. The immunocomplexed protein was incubated with anti-pLLGL1/2 (S650/S654) primary antibody overnight at 4 C, followed by an automated wash and then addition of HRP-conjugated secondary antibody. After a further wash, 3,3',5,5'-tetramethylbenzidine (Sigma) was added according to the manufacturer's instructions and attenuance was read at 450 nm using an Ascent plate reader (Thermo Labsystems).
Kinase Selectivity CRT0103390 was profiled using the KINOMEscan in vitro competition binding screening platform at DiscoveRx against a panel of 442 mutant and non-mutant kinases at a test concentration of 1 mM. Selectivity scores were calculated as the number of non-mutant kinases with % activity relative to control < 20/number of non-mutant kinases tested. CRT0103390 demonstrated a high degree of selectivity in this panel, with an S(80) of 0.09.
QUANTIFICATION AND STATISTICAL ANALYSIS
Image Analysis -General All image analysis was performed in Fiji (ImageJ) (Schindelin et al., 2012) and Matlab (Mathworks).
Image Analysis -Asymmetry Index (ASI) The asymmetry index (ASI) of a feature is defined by:
A À P 2ðA + PÞ where A and P define the anterior and posterior signal, respectively. Raw ASI values are normalized to the mean ASI observed in respective controls, such that a value of 1 indicates wild-type asymmetry and zero indicates complete loss of asymmetry. Anterior and posterior signals are defined depending on the condition examined and include cross-sectional area (AB vs P1 asymmetry), fluorescence intensity on the two cell halves for the membrane (midsection PAR analysis) or cytoplasm (MEX-5, PIE-1), or cluster number (CHIN-1).
Image Analysis -Cluster Index
The Cluster Index is defined as the variance in cortical intensity within the anterior domain. It was calculated in Matlab across user specified ROIs that were subject to background subtraction and normalization to mean intensity before analysis.
Image Analysis -CHIN-1 Foci CHIN-1 foci were identified using the feature2D.m script, part of the feature detection and particle tracking package from the Kilfoil Lab (Pelletier et al., 2009) . Embryos were automatically detected and partitioned into 3 domains (Anterior, Middle, Posterior) and normalized anterior vs posterior particle densities used for ASI calculation.
Image Analysis -MEX-5 Mobility For MEX-5 mobility, five pre-bleach frames were captured by spinning disk confocal microscopy. A central 20-pixel wide stripe was then bleached along the AP axis using a 473 diode laser (Obis) and recovery was monitored every 2 s. Because MEX-5 is uniform in the quantified conditions, fluorescence was monitored within a central 20 x 100-pixel box.
Image Analysis -Colocalization Colocalization analysis of PAR-6 and PAR-3 was performed in ROIs at the anterior cortex of establishment phase zygotes (wild-type n=8 and pkc-3(ts) n=9). Costes' Mask and intensity correlation quotient (Li et al., 2004) were obtained using JaCOP plug-in in Fiji.
Image Analysis -Flow Speeds Anterior-directed cortical flow speed during establishment phase was measured using midplane, brightfield images acquired every second until late establishment phase at which point we switched to fluorescent imaging to obtain suitable images for measuring PAR asymmetry. Using the Kymograph Plugin in Fiji (Seitz and Surrey, 2006) , we generated kymographs for individual embryos by tracing a segmented line along the cortex starting at the origin of flow. A minimum of 10 yolk granule trajectories, each spanning approximately 200s were selected for a minimum of 5 embryos per condition. The cortical flow velocity was defined as the total distance over time calculated from a line connecting the start and end positions of the granule on the kymograph. Measurement of cortical flow in wild-type embryos expressing GFP fusions to PAR-3, PKC-3 or CDC-42 yielded a velocity of 7.1+/-1.4 mm/min (n=22), consistent with previously published values (7.66+/-1.0 mm/min, n=6) (Munro et al., 2004) .
Image Analysis -Anterior Cortical Intensity (Immunofluorescence) Anterior cortical intensity of each PAR protein is the mean greyscale value of a line 2 pixels wide (in each corresponding fluorescent channel) covering the PAR-3 cortical domain of the zygote. The cortical intensity value is then normalized by dividing it by the mean greyscale value of a nearby cytoplasmic region to correct for embryo IF staining variability. In par-3(RNAi) zygotes, we cannot distinguish anterior from posterior cortex and the entire cortex of zygotes is analyzed. Each experimental condition was analyzed in three independent experiments.
Image Analysis -Anterior PAR Retraction (Immunofluorescence) The posterior boundary of anterior PARs in fixed, midsection fluorescent images is defined at the intersection between the equatorial zygote line (longest line linking the zygotes' poles) and the line that links the cortical ends (top and bottom) of the PAR protein analyzed. Retraction is the distance between this posterior boundary and the posterior pole of the zygote. Retraction difference is defined as the difference in retraction distance between PAR-3 and PKC-3. Data were collected from three independent experiments.
Image Analysis -Intensity Profile Extraction
In general, to assess PAR signal from midsection images, a 60-pixel wide stripe encompassing the cell membrane was extracted and straightened to generate a profile for each embryo for further analysis.
For spatial analysis (ASI, profile plots, domain size, segregation efficiency), the top 4 central pixels corresponding to the membrane were taken at each x-position and averaged to the given local membrane signal. Background and cytoplasmic signal were calculated locally from inner and outer edges of this stripe, allowing normalization for variation in signal between conditions. Briefly, background was subtracted and then membrane divided by cytoplasmic intensity.
Image Analysis -PAR-3 versus PKC-3 Cortical Profile Comparison (Immunofluorescence)
To quantitatively compare PAR cortical profiles in multi-labelled fixed embryos, two identical profiles along the cortex were extracted in each channel as above. Each set of profiles was split in half to generate two boundary regions. After normalization to maximum and minimum values, profiles were registered using the inflection point, c, based on fitting each PAR-3 profile using the following function:
where erf is the error function, c is the domain boundary position, m the boundary slope and a and b allow for scaling and displacement on the y-axis.
Image Analysis -Domain Size/Segregation Efficiency To extract domain size data (PAR-2 domain size change, segregation efficiency) from single channel images, cortical fluorescence profiles were normalized to total embryo perimeter length and aligned to the center of posterior PAR domain determined by fitting the profile to the following function:
with the center of the posterior domain specified by:
posterior domain size given by:
and anterior domain size given by:
where L is the length of the profile. PAR-2 domain size change for each embryo was calculated as the ratio of domain size taken from images before and 5 min after PMA addition. Segregation efficiency into the anterior was scored by relative anterior domain size, with smaller anterior domains defined as more efficient segregation.
Image Analysis -Total Membrane Signal Change To estimate total membrane signal in PAR-6 and PKC-3 rescue experiments straightened profiles were projected in x to give a crosssection profile spanning background, crossing the membrane and into the cytoplasm for the full circumference. Cross-section profiles were then normalized with background = 0 and cytoplasm = 1. To get the most accurate estimate of isolated membrane signal, we generated a mean cross-section for embryos with no detectable membrane signal from par-3 and par-6 RNAi embryos to define the shape of the outside to inside fluorescence step. The shape of this curve was extremely consistent allowing a mean profile to be generated, which could then be subtracted from individual embryo cross-section profiles with the sum of the difference taken as membrane signal.
For PAR-2 retention in C1B-induced PKC-3 membrane-targeting experiments, a cytoplasm-normalized 4-pixel wide stripe encompassing the cell membrane was taken from images before and 5 min after PMA addition to generate profiles. PAR-2 retention was defined as the ratio of total membrane signal before and after PMA addition.
Statistics
For all assays, significance was assessed using an unpaired, two-tail Student's T test unless otherwise noted with the following criteria: *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Data are presented as mean values plus all data points or mean ± 95% confidence interval (CI), in which case (N) is indicated.
Data and Software Availability
Sequence data for pkc-3(ne4246) has been submitted to Wormbase (WB Gene: pkc-3).
